REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 188 filers reported holding REGENXBIO INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,460 | -17.7% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $19,990 | +5.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $18,910 | +82117.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $23 | -99.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $26,000 | +4.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $25,000 | -24.2% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $33,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $33,000 | -21.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $42,000 | +7.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $39,000 | +14.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $34,000 | -24.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $45,000 | +60.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $28,000 | -24.3% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $37,000 | +15.6% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $32,000 | -22.0% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $41,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 415,664 | $15,309,000 | 7.62% |
| Aquilo Capital Management, LLC | 553,453 | $20,384,000 | 4.11% |
| ArchPoint Investors | 300,961 | $11,084,000 | 3.55% |
| Burrage Capital Management LLC | 115,000 | $4,235,000 | 2.96% |
| P.A.W. CAPITAL CORP | 70,000 | $2,578,000 | 2.92% |
| WS MANAGEMENT LLLP | 436,828 | $16,088,000 | 1.97% |
| Redmile Group, LLC | 2,236,766 | $82,380,000 | 1.52% |
| BRANDYWINE MANAGERS, LLC | 6,200 | $228,000 | 0.94% |
| Pier Capital, LLC | 94,433 | $3,478,000 | 0.56% |
| RTW INVESTMENTS, LP | 316,028 | $11,639,000 | 0.33% |